Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the Effect of Fipamezole on Neurogenic Orthostatic Hypotension in Patients With Multiple System Atrophy or Parkinson's Disease

NCT00758849 is registered in ClinicalTrials.gov with Juvantia Pharma Ltd as lead sponsor.

NCT NCT00758849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00758849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomised, Placebo-Controlled, Double-Blind, Replicated Crossover, Pilot Study on the Effect of Fipamezole on Neurogenic Orthostatic Hypotension in Patients With Multiple System Atrophy or Parkinson's Disease
Lead sponsor
Juvantia Pharma Ltd
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2008
Completion date
May 31, 2009
Enrollment
24 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy, parkinson's disease, symptomatic neurogenic orthostatic hypotension (noh)